BioNexus Gene Lab完成对Fidelion Diagnostics的战略投资,获得全球AI肿瘤平台15%的股权

投资观察
Dec 03, 2025

12月3日 - BioNexus Gene Lab Corp. :*BioNexus Gene Lab Corp. 完成对Fidelion Diagnostics的战略投资;获得全球AI肿瘤平台15%的股权以及Vitagard™在东南亚的独占权益*。BioNexus Gene Lab Corp. 购买了Fidelion Diagnostics 15%的股权。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10